TY  - RPRT
U1  - Forschungsbericht
A1  - Hoitink, Lars
A1  - Castillo, Carmen
A1  - Quetglas, Joan
A1  - Chung, I-Chen
A1  - Deutsch, Nina
T1  - What will the future of CRISPR - Cas 9 in Germany look like in 2035? Scenario planning
N2  - The longevity industry has been expanding for several years now, with the goal to prolong not only the lifespan of people but also their healthspan. One of the most remarkable techniques in the field is the CRISPR Cas-9 gene-editing tool, which owing to its flexibility and efficiency, allows humans to develop new treatments to prevent or cure a great variety of diseases. This paper aims to forecast the future state of the CRISPR Cas-9 technology in Germany in 2035 by using the INKA 4 scenario manager software. A total of five areas of influence –– i.e. scientific, economic, demographic, ethical, and legal –– were identified. From those, 11 descriptors were created based on relevant scientific literature and were introduced in the INKA software to develop the scenarios. This process resulted in three clearly differentiated scenarios that exhibit high probabilities of a positive outlook for the CRISPR-Cas9 technology in Germany by 2035.
KW  - Scenario Planning
KW  - CRISPR-Cas9
KW  - Longevity Research
KW  - INKA4
Y2  - 2021
U6  - https://nbn-resolving.org/urn:nbn:de:bsz:fn1-opus4-74320
UN  - https://nbn-resolving.org/urn:nbn:de:bsz:fn1-opus4-74320
SP  - 94
S1  - 94
ER  -